Cancer Ablation UK Limited 08257289 false 2017-04-01 2018-07-31 2018-07-31 The principal activity of the company is specialist medical practice Digita Accounts Production Advanced 6.21.8540.0 Software true 08257289 2017-04-01 2018-07-31 08257289 2018-07-31 08257289 core:CurrentFinancialInstruments core:WithinOneYear 2018-07-31 08257289 bus:Micro-entities 2017-04-01 2018-07-31 08257289 bus:AuditExemptWithAccountantsReport 2017-04-01 2018-07-31 08257289 bus:FullAccounts 2017-04-01 2018-07-31 08257289 bus:SmallCompaniesRegimeForAccounts 2017-04-01 2018-07-31 08257289 bus:RegisteredOffice 2017-04-01 2018-07-31 08257289 bus:Director1 2017-04-01 2018-07-31 08257289 bus:Director2 2017-04-01 2018-07-31 08257289 bus:PrivateLimitedCompanyLtd 2017-04-01 2018-07-31 08257289 countries:AllCountries 2017-04-01 2018-07-31 08257289 2017-03-31 08257289 core:CurrentFinancialInstruments core:WithinOneYear 2017-03-31 iso4217:GBP

Registration number: 08257289

Cancer Ablation UK Limited

Annual Report and Unaudited Financial Statements

for the Period from 1 April 2017 to 31 July 2018

 

Cancer Ablation UK Limited

(Registration number: 08257289)
Balance Sheet as at 31 July 2018

2018
£

2017
£

Current assets

-

251

Creditors: Amounts falling due within one year

(2,166)

(4,735)

Total assets less current liabilities

(2,166)

(4,484)

Accruals and deferred income

(390)

(313)

 

(2,556)

(4,797)

Capital and reserves

(2,556)

(4,797)

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Beech House
South Lane
Nomansland
Salisbury
Wilts
SP5 2BZ

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the financial period ending 31 July 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Cancer Ablation UK Limited

(Registration number: 08257289)
Balance Sheet as at 31 July 2018

Approved and authorised by the Board on 17 October 2018 and signed on its behalf by:
 

.........................................

Dr D J Breen
Director

.........................................

Dr N A McGill
Director